Microbiota-Derived Metabolite Enhances HIV Therapy in Monkeys
The metabolite 10-hydroxystearic acid (10-HSA), from Lactiplantibacillus plantarum, repaired HIV-related gut damage, reduced inflammation, restored immunity, and improved antiretroviral therapy effectiveness in preclinical primate studies, supporting future human trials.
The post Microbiota-Derived Metabolite Enhances HIV Therapy in Monkeys appeared first on GEN - Genetic Engineering and Biotechnology News.
